Skip to main content
Premium Trial:

Request an Annual Quote

Matthew Posard

Matthew Posard has joined Trovagene as executive vice president and chief commercial officer. He joins the company from Illumina where he was senior vice president and general manager for the company's new and emerging marketing opportunities business. He also has served as the general manager of Illumina's translational and consumer genomics business and vice president of global marketing. Prior to Illumina, he had leadership roles in sales and marketing at Biosite and worked in strategic and product manufacturing at Gen-Probe, now part of Hologic.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.